SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows … – MarketWatch (press release)

SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows
MarketWatch (press release)
More than 22 million Americans are living with asthma, including 2.3+ million African Americans. "These findings provide important information about the use of SYMBICORT in African-American patients with persistent asthma, and may help guide healthcare
AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in StreetInsider.com (subscription)

all 4 news articles »

View full post on asthma – Google News

Budesonide/Formoterol for Asthma Shows Cardiovascular Safety – Family Practice News Digital Network

Budesonide/Formoterol for Asthma Shows Cardiovascular Safety
Family Practice News Digital Network
ORLANDO – Budesonide/formoterol pressurized metered-dose inhaler demonstrated similar cardiovascular safety to that of budesonide treatment alone in a study of 742 black adolescents and adults with moderate to severe asthma. There has been concern that

View full post on asthma – Google News

Overall asthma control achieved with budesonide/formoterol maintenance and … – 7thSpace Interactive (press release)

Overall asthma control achieved with budesonide/formoterol maintenance and
7thSpace Interactive (press release)
Adjusting medication for uncontrolled asthma involves selecting one of several options from the same or a higher treatment step outlined in asthma guidelines. We examined the relative benefit of introducing budesonide/formoterol (BUD/FORM) maintenance

View full post on asthma – Google News